Delivery of rapamycin by biomimetic peptide nanoparticles targeting oxidized low-density lipoprotein in atherosclerotic plaques-Reference-Cited by-同舟云学术

Delivery of rapamycin by biomimetic peptide nanoparticles targeting oxidized low-density lipoprotein in atherosclerotic plaques

Published:2024 Issue:16 Volume:12 Page:4181-4193
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Wang Anqi¹^ORCID,Yue Kai¹²^ORCID,Zhong Weishen¹,Zhang Genpei¹,Wang Lei³^ORCID,Zhang Hua⁴,Zhang Xinxin¹²

Affiliation:

1. School of Energy and Environmental Engineering, University of Science and Technology Beijing, Beijing 100083, China

2. Shunde Graduate School of University of Science and Technology Beijing, Shunde, Guangdong Province, 528399, China

3. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China

4. Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

Abstract

Multifunctional peptides can effectively load RAPA and target oxLDL within plaques, suggesting that these peptides have potential as therapeutic agents for atherosclerotic disease.

Funder

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00367E

Reference34 articles.

1. Nanoparticle-based drug delivery systems for cancer therapy

2. Computational and experimental approaches for investigating nanoparticle-based drug delivery systems

3. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures

4. Nanomaterials for cancer therapy: current progress and perspectives

5. Dimeric Drug Polymeric Nanoparticles with Exceptionally High Drug Loading and Quantitative Loading Efficiency